Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT06377566
Conditions
Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Brentuximab vedotin
Doxorubicin
Vinblastine
Dacarbazine
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-01-30.